BiotechTube
Home/Prota Therapeutics/Dr. Mark Hasleton
DM

Dr. Mark Hasleton

Acting CEO

Prota Therapeutics

Therapeutic Areas

Immunology

Prota Therapeutics Pipeline

DrugIndicationPhase
PRT120Peanut allergyPhase 3

Leadership Team at Prota Therapeutics

PM
Prof. Mimi Tang
Founding CEO & Scientific Founder
CJ
Cameron Jones
Chief Financial Officer
PM
Patrick Machado
Chair, Board of Directors
DP
Dr. Paul Kelly
Director, OneVentures
AD
Adam Deutsch
Director, SPRIM Global Investments
View full Prota Therapeutics profile